Univec, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a UNVC research report →
About the company
Univec, Inc. is a medical device firm that, through its various operating divisions, develops, licenses, and sells products across the United States and internationally. Its primary offerings include a range of auto-disable and safety syringes.
- CEO
- David Dalton
- IPO
- 1997
- Employees
- 3
- HQ
- Owings Mills, MD, US
Price Chart
- Market Cap
- $8.07M
- P/E
- 16.00
- P/S
- 91.73
- P/B
- -0.45
- EV/EBITDA
- -7.54
- Div Yield
- 0.00%
- Gross Margin
- 13.66%
- Op Margin
- -1441.94%
- Net Margin
- -1377.32%
- ROE
- 6.94%
- ROIC
- 7.67%
- Revenue
- $85.01K · 130.97%
- Net Income
- $-1,215,374 · 1.85%
- EPS
- $0.00 · 200.00%
- Op Income
- $-1,203,115
- FCF YoY
- -28175.02%
- 52W High
- $0.01
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 0.97
- Avg Volume
- 1.57M
Get TickerSpark's AI analysis on UNVC
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our UNVC coverage
Recent articles, reports, and earnings notes.
No research on UNVC yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate UNVC report →Similar companies
Peers in the same neighborhood.